258 related articles for article (PubMed ID: 23984511)
1. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
[TBL] [Abstract][Full Text] [Related]
2. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
3. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
4. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
[TBL] [Abstract][Full Text] [Related]
5. An update on HLA alleles associated with adverse drug reactions.
Fricke-Galindo I; LLerena A; López-López M
Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
Borroni RG
G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
Kaniwa N; Saito Y
J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
[TBL] [Abstract][Full Text] [Related]
8. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of hypersensitivity drug reactions.
Negrini S; Becquemont L
Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
[TBL] [Abstract][Full Text] [Related]
10. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
12. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
Aoki S
Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
[TBL] [Abstract][Full Text] [Related]
13. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
[TBL] [Abstract][Full Text] [Related]
14. Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.
Ramsbottom KA; Carr DF; Jones AR; Rigden DJ
Mol Immunol; 2018 Sep; 101():488-499. PubMed ID: 30125869
[TBL] [Abstract][Full Text] [Related]
15. HLA and Delayed Drug-Induced Hypersensitivity.
Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen and idiosyncratic adverse drug reactions.
Usui T; Naisbitt DJ
Drug Metab Pharmacokinet; 2017 Feb; 32(1):21-30. PubMed ID: 28017537
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
Xiong Y; Zhang W; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):749-57. PubMed ID: 25080918
[TBL] [Abstract][Full Text] [Related]
18. HLA Association with Drug-Induced Adverse Reactions.
Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
[TBL] [Abstract][Full Text] [Related]
19. HLA-B*1502 screening and toxic effects of carbamazepine.
Phillips EJ; Mallal SA
N Engl J Med; 2011 Aug; 365(7):672; author reply 673. PubMed ID: 21848472
[No Abstract] [Full Text] [Related]
20. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
